These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2618906)

  • 21. Occupational bladder cancer.
    Tepper LB
    J Ky Med Assoc; 1974 Mar; 72(3):135-8. PubMed ID: 4815653
    [No Abstract]   [Full Text] [Related]  

  • 22. Notification of a cohort of workers at risk of bladder cancer.
    Schulte PA; Ringen K; Altekruse EB; Gullen WH; Davidson K; Anderson SS; Patton MG
    J Occup Med; 1985 Jan; 27(1):19-28. PubMed ID: 2982002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
    Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined action of aminoderivatives of diphenyl, substances inducing neoplasms of the urinary bladder].
    Shabad LM; Genin VA
    Urol Nefrol (Mosk); 1975; (1):38-42. PubMed ID: 1118972
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant cells in the urine of men exposed to beta-naphthylamine.
    Connolly JG; White EP
    Can Med Assoc J; 1969 May; 100(19):879-82. PubMed ID: 5789538
    [No Abstract]   [Full Text] [Related]  

  • 26. An assessment of the effect of improved working conditions on bladder tumor incidence in a benzidine manufacturing facility.
    Ferber KH; Hill WJ; Cobb DA
    Am Ind Hyg Assoc J; 1976 Jan; 37(1):61-8. PubMed ID: 1246951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of occupational uroepithelial cancer].
    Hamasaki T; Aramaki K; Hida T; Inatomi H; Fujimoto N; Okamura T; Ozu K; Sugita A
    J UOEH; 1996 Dec; 18(4):247-59. PubMed ID: 8981648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Training needs and role of general practitioners for preventing measures and medical surveillance of ex-exposed to occupational carcinogens].
    Iavicoli S; Della Porta G; Natali E; Persechino B; Petyx M; Rondinone B; Pira E
    G Ital Med Lav Ergon; 2005; 27(3):293-6. PubMed ID: 16240577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience of tumors in a British plant handling 3 3' dichlorobenzidine.
    MacIntyre DI
    J Occup Med; 1975 Jan; 17(1):23-6. PubMed ID: 1123675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Occupational bladder cancer].
    Hinke K; Lings S
    Ugeskr Laeger; 1994 Jan; 156(1):62-3. PubMed ID: 8291161
    [No Abstract]   [Full Text] [Related]  

  • 31. [Occupational exposure and bladder cancer].
    Conso F
    Rev Prat; 2004 Oct; 54(15):1665-70. PubMed ID: 15605580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Present aspects and problems regarding occupational bladder cancer due to exposure to aromatic amines].
    Yamamura J
    J UOEH; 1989 Dec; 11(4):495-504. PubMed ID: 2692109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bladder cancer among chemical workers exposed to nitrogen products and other substances.
    Marsh GM; Gula MJ; Youk AO; Cassidy LD
    Am J Ind Med; 2002 Oct; 42(4):286-95. PubMed ID: 12271476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An epidemiological study of occupational bladder tumours in the dye industry of Japan.
    Tsuchiya K; Okubo T; Ishizu S
    Br J Ind Med; 1975 Aug; 32(3):203-9. PubMed ID: 1156568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess.
    Stephens ER
    J Natl Cancer Inst; 1997 May; 89(10):734-5; author reply 735-6. PubMed ID: 9168192
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemical factors as causes of bladder cancer].
    Bédard G
    Laval Med; 1970 Jan; 41(1):27-31. PubMed ID: 5515120
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biochemistry of occupational bladder cancer].
    Matsushima M; Ando K
    Hinyokika Kiyo; 1983 Nov; 29(11):1383-94. PubMed ID: 6375309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
    Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
    J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a national register on occupational exposure to carcinogens: effectiveness in the prevention of occupational cancer, and cancer risks among the exposed workers.
    Kauppinen T; Saalo A; Pukkala E; Virtanen S; Karjalainen A; Vuorela R
    Ann Occup Hyg; 2007 Jul; 51(5):463-70. PubMed ID: 17625219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of the occupational carcinogen legislation in the European Community].
    Soulat JM; Pujol M
    Bull Cancer; 1997 Feb; 84(2):199-205. PubMed ID: 9180845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.